ELIZABETH SMITH: Open Payments
NPI 1730712985 · WATERLOO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,300 in 111 payments from 21 companies in 2025. Trend: 2023 $1,708 · 2024 $2,115 · 2025 $2,300
Food & beverage: $2,300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $429 |
| PFIZER INC. | 22 | $334 |
| ABBVIE INC. | 15 | $273 |
| Novo Nordisk Inc | 10 | $194 |
| GlaxoSmithKline, LLC. | 7 | $161 |
| Otsuka America Pharmaceutical, Inc. | 5 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $120 |
| Exact Sciences Corporation | 5 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $115 |
| Astellas Pharma US Inc | 2 | $68 |
Products named: AIRSUPRA, VRAYLAR, REXULTI, TRELEGY ELLIPTA, PREVNAR 20, CAPLYTA, JARDIANCE, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
